GPCR NewsJan 31, 20221 min readErmium Therapeutics has constituted its SABUpdated: Aug 23, 2022February 2022"Ermium Therapeutics Announces the Formation of a Scientific Advisory Board comprising international leaders in GPCRs pharmacology, immunology, drug discovery and development for auto-immune diseases"Read more at the source#DrGPCR #GPCR #IndustryNews
February 2022"Ermium Therapeutics Announces the Formation of a Scientific Advisory Board comprising international leaders in GPCRs pharmacology, immunology, drug discovery and development for auto-immune diseases"Read more at the source#DrGPCR #GPCR #IndustryNews
Emerging approaches for decoding neuropeptide transmissionNovember 2022 "Neuropeptides produce robust effects on behavior across species, and recent research has benefited from advances in...
Location bias contributes to functionally selective responses of biased CXCR3 agonistsNovember 2022 "Some G protein-coupled receptor (GPCR) ligands act as "biased agonists" that preferentially activate specific signaling...
Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell...November 2022 Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell cycle and metastasis...
댓글